Daclatasvir Impurity 7

Daclatasvir Impurity 7 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

1,1''-(2S,2''S)-2,2''-(5,5''-([1,1''-Biphenyl]-4,4''-diyl)bis[1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))diethanone is derived from 5,5''-[1,1''-Biphenyl]-4,4''-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole] Hydrochloride (B397775), which is the derivative of Daclatasvir (D101500) that inhibits the HCV protein NS5A, and thus can be used a drug candidate for the treatment of hepatitis C (HCV).

Daclatasvir Impurity 7 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Daclatasvir Impurity 7 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 13028896684	sales@rrkchem.com	China	56057	58
Cato Research Chemicals Inc.	020-81215950 4000-868-328	customer@uwalab.com	United States	10413	58
Wuxi Minglu Medicine technology Co.,Ltd.	0510-88726693	3204601684@qq.com	China	2216	58
Shenzhen Roark Pharma-Tec Co., Ltd.	13128912434	2880126944@qq.com	China	2579	58

---

• Daclatasvir Impurity 7
• 1,1''-((2S,2''S)-([1,1''-biphenyl]-4,4''-diylbis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(ethan-1-one)
• 1,1'-(2S,2'S)-2,2'-(5,5'-([1,1'-Biphenyl]-4,4'-diyl)bis[1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))diethanone
• Ethanone, 1,1'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl]]bis-
• Daclatasvir impurity 12/1,1’-(2S,2’S)-2,2’-(5,5’-([1,1’-Biphenyl]-4,4’-diyl)bis[1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))diethanone
• 1447744-93-5